During the past decade, Holy Family Memorial Hospital conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 98 clinical trials were completed, i.e. on average, 178.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 51 clinical trials were completed. i.e. 566.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holy Family Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 81 trials, followed by "SWOG Cancer Research Network" with 21 trials sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "Gynecologic Oncology Group" with 8 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holy Family Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 66 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Holy Family Memorial Hospital" are "Recurrent Breast Carcinoma" (11 trials), "Recurrent Ovarian Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (8 trials) and "Recurrent Fallopian Tube Carcinoma" (7 trials). Many other conditions were trialed in "Holy Family Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Holy Family Memorial Hospital" are "Drug" (123 trials), "Other" (112 trials), "Biological" (66 trials), "Procedure" (25 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (76 trials), "Quality-of-Life Assessment" (34 trials), "Paclitaxel" (23 trials), "Bevacizumab" (19 trials) and "Carboplatin" (18 trials). Other intervention names were less common.

The vast majority of trials in "Holy Family Memorial Hospital" are 111 trials for "All" genders, 35 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Holy Family Memorial Hospital". undefined are not yet recruiting, 11 are recruiting, 70 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Holy Family Memorial Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Holy Family Memorial Hospital, 5 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 81 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Holy Family Memorial Hospital has several departments that took part in Clinical trials: "Holy Family Memorial Medical Center Cancer Care Center" - 64 trials